![Karen Adams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karen Adams
Finanzdirektor/CFO bei Aerial BioPharma LLC
Profil
Karen Adams is currently the Chief Financial Officer at Aerial BioPharma LLC since 2015.
Prior to her current position, she worked as an Internal Auditor at International Paper Co., Assistant Controller at Millennium Pharmaceuticals, Inc., and held Principal positions at BG Medicine, Inc., Galenea Corp., Micell Technologies, Inc., and Surface Logix LLC.
She also served as the Chief Financial Officer at Addrenex Pharmaceuticals, Inc. and held a Principal position at Adnexus.
Ms. Adams received her undergraduate degree from Boston College.
Aktive Positionen von Karen Adams
Unternehmen | Position | Beginn |
---|---|---|
Aerial BioPharma LLC
![]() Aerial BioPharma LLC Pharmaceuticals: MajorHealth Technology Aerial BioPharma LLC operates as a biopharmaceutical company. It focuses on developing biologics and small molecules for conditions that are affected by processes in the Central Nervous System. The company was founded by Moise A. Khayrallah, stephen E. Butts and Gary Bream in January 2011 and is headquartered in Morrisville, NC. | Finanzdirektor/CFO | 01.09.2015 |
Ehemalige bekannte Positionen von Karen Adams
Unternehmen | Position | Ende |
---|---|---|
Micell Technologies, Inc.
![]() Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Galenea Corp.
![]() Galenea Corp. Pharmaceuticals: MajorHealth Technology Galenea Corp. is an emerging biotechnology company which engaged in the discovery of novel therapies for central nervous system (CNC) and respiratory diseases. The firm is focusing initially on utilizing proprietary technologies to generate calcineurin-related treatments for schizophrenia. It also offers synaptic transmission drug discovery platform for alzheimer’s disease (AD), parkinson’s disease, huntington’s disease, epilepsy, bipolar depression, schizophrenia, autism spectrum disorders, and traumatic brain injury. The company was founded Jianzhu chen, Susumu Tonegawa, Maria Karayiorgou, and David J. Gerber in 2004 and is headquartered in Wakefield, MA. | Corporate Officer/Principal | - |
BG MEDICINE, INC. | Corporate Officer/Principal | - |
Adnexus
![]() Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Surface Logix LLC
![]() Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Karen Adams
Boston College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
INTERNATIONAL PAPER COMPANY | Process Industries |
BG MEDICINE, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Aerial BioPharma LLC
![]() Aerial BioPharma LLC Pharmaceuticals: MajorHealth Technology Aerial BioPharma LLC operates as a biopharmaceutical company. It focuses on developing biologics and small molecules for conditions that are affected by processes in the Central Nervous System. The company was founded by Moise A. Khayrallah, stephen E. Butts and Gary Bream in January 2011 and is headquartered in Morrisville, NC. | Health Technology |
Addrenex Pharmaceuticals, Inc.
![]() Addrenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Addrenex Pharmaceuticals, Inc. manufactures pharmaceuticals and drugs. Its focus on adrenergic regulation is indicated in therapeutic categories such as hypertension, ADHD, migraine and post-menopausal symptoms. The company was founded by H. Joseph Horacek and Moise A. Khayrallah in June 2006 and is headquartered in Durham, NC. | Health Technology |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Surface Logix LLC
![]() Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Health Technology |
Adnexus
![]() Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Health Technology |
Galenea Corp.
![]() Galenea Corp. Pharmaceuticals: MajorHealth Technology Galenea Corp. is an emerging biotechnology company which engaged in the discovery of novel therapies for central nervous system (CNC) and respiratory diseases. The firm is focusing initially on utilizing proprietary technologies to generate calcineurin-related treatments for schizophrenia. It also offers synaptic transmission drug discovery platform for alzheimer’s disease (AD), parkinson’s disease, huntington’s disease, epilepsy, bipolar depression, schizophrenia, autism spectrum disorders, and traumatic brain injury. The company was founded Jianzhu chen, Susumu Tonegawa, Maria Karayiorgou, and David J. Gerber in 2004 and is headquartered in Wakefield, MA. | Health Technology |
Micell Technologies, Inc.
![]() Micell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Micell Technologies, Inc. operates as a biomedical device company. It develops interventional cardiology systems for vascular drug delivery. The firm offers MiStent SES is designed to optimize healing in patients with coronary artery disease. The company was founded by Joseph M. DeSimone and James B. McClain in 1995 and is headquartered in Durham, NC. | Health Technology |